Skip to main content
Diabetology & Metabolic Syndrome logoLink to Diabetology & Metabolic Syndrome
. 2024 Mar 25;16:76. doi: 10.1186/s13098-024-01314-y

Correction: Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study

Ingrid Lea Scully 1, Lisa Kristin McNeil 1, Sudam Pathirana 1, Christine Lee Singer 1, Yongdong Liu 1, Stanley Mullen 1, Douglas Girgenti 1, Alejandra Gurtman 1, Michael W Pride 1, Kathrin Ute Jansen 1, Paul L Huang 2, Annaliesa S Anderson 1,
PMCID: PMC10962187  PMID: 38528575

Correction: Diabetol Metab Syndr (2017) 9:76

10.1186/s13098-017-0276-3

After publication we became aware that the Acknowledgements section in our article [1] was incomplete. It should read as follows:

“Medical writing support was provided by Sharmila Blows, Ph.D., of Engage Scientific Solutions, and was funded by Pfizer. Johanna Hoyos, a former scientist at Pfizer-Wyeth, developed and performed the chemotaxis assay.”

Footnotes

The online version of the original article can be found at 10.1186/s13098-017-0276-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Scully IL, McNeil LK, Pathirana S, et al. Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study. Diabetol Metab Syndr. 2017;9:76. doi: 10.1186/s13098-017-0276-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Diabetology & Metabolic Syndrome are provided here courtesy of BMC

RESOURCES